158 related articles for article (PubMed ID: 11601883)
1. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
[TBL] [Abstract][Full Text] [Related]
2. Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion.
Jianmongkol S; Marable BR; Berkman CE; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 1999 Feb; 155(1):43-53. PubMed ID: 10036217
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective inactivation of Torpedo californica acetylcholinesterase by isomalathion: inhibitory reactions with (1R)- and (1S)-isomers proceed by different mechanisms.
Doorn JA; Thompson CM; Christner RB; Richardson RJ
Chem Res Toxicol; 2003 Aug; 16(8):958-65. PubMed ID: 12924923
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of acetylcholinesterase by (1S,3S)-isomalathion proceeds with loss of thiomethyl: kinetic and mass spectral evidence for an unexpected primary leaving group.
Doorn JA; Gage DA; Schall M; Talley TT; Thompson CM; Richardson RJ
Chem Res Toxicol; 2000 Dec; 13(12):1313-20. PubMed ID: 11123973
[TBL] [Abstract][Full Text] [Related]
5. Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase.
Doorn JA; Talley TT; Thompson CM; Richardson RJ
Chem Res Toxicol; 2001 Jul; 14(7):807-13. PubMed ID: 11453726
[TBL] [Abstract][Full Text] [Related]
6. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
7. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the postinhibitory reactions of acetylcholinesterase poisoned by chiral isomalathion: a surprising nonreactivation induced by the RP stereoisomers.
Berkman CE; Ryu S; Quinn DA; Thompson CM
Chem Res Toxicol; 1993; 6(1):28-32. PubMed ID: 8448346
[TBL] [Abstract][Full Text] [Related]
10. Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro.
Jianmongkol S; Berkman CE; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 1996 Aug; 139(2):342-8. PubMed ID: 8806851
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
12. Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry.
Jennings LL; Malecki M; Komives EA; Taylor P
Biochemistry; 2003 Sep; 42(37):11083-91. PubMed ID: 12974645
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an on-target sample preparation system for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in conjunction with normal-flow peptide high-performance liquid chromatography for peptide mass fingerprint analyses.
McComb ME; Perlman DH; Huang H; Costello CE
Rapid Commun Mass Spectrom; 2007; 21(1):44-58. PubMed ID: 17133622
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
Guo Z; Wagner CR; Hanna PE
Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
[TBL] [Abstract][Full Text] [Related]
16. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
[TBL] [Abstract][Full Text] [Related]
17. Structural approach to the aging of phosphylated cholinesterases.
Masson P; Nachon F; Lockridge O
Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
19. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging.
Nachon F; Asojo OA; Borgstahl GE; Masson P; Lockridge O
Biochemistry; 2005 Feb; 44(4):1154-62. PubMed ID: 15667209
[TBL] [Abstract][Full Text] [Related]
20. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
